{"id":13799,"date":"2017-07-10T08:32:00","date_gmt":"2017-07-10T08:32:00","guid":{"rendered":"https:\/\/celonpharma.com\/?p=13799"},"modified":"2018-02-08T08:32:48","modified_gmt":"2018-02-08T08:32:48","slug":"celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/","title":{"rendered":"Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products"},"content":{"rendered":"<p><a href=\"https:\/\/celonpharma.com\/wp-content\/uploads\/2018\/02\/20170710_Celon-Pharma-S.A.-received-a-positive-assessment-and-funding-recommendation-from-the-National-Centre-for-Research-and-Development-NCBiR-for-3-projects-of-developing-in.doc\">20170710_Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing in<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>20170710_Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing in<\/p>\n","protected":false},"author":11,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[57],"tags":[],"class_list":["post-13799","post","type-post","status-publish","format-standard","hentry","category-press-materials"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"20170710_Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing in\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2017-07-10T08:32:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-02-08T08:32:48+00:00\" \/>\n<meta name=\"author\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"S\u0142awomir Ni\u017cnik\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\\\/\"},\"author\":{\"name\":\"S\u0142awomir Ni\u017cnik\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"headline\":\"Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products\",\"datePublished\":\"2017-07-10T08:32:00+00:00\",\"dateModified\":\"2018-02-08T08:32:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\\\/\"},\"wordCount\":52,\"articleSection\":[\"Press Materials\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\\\/\",\"name\":\"Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"datePublished\":\"2017-07-10T08:32:00+00:00\",\"dateModified\":\"2018-02-08T08:32:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/44c54386ed112173d6e8bcbeb6425338\",\"name\":\"S\u0142awomir Ni\u017cnik\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/","og_locale":"en_US","og_type":"article","og_title":"Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products - Celon Pharma","og_description":"20170710_Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing in","og_url":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/","og_site_name":"Celon Pharma","article_published_time":"2017-07-10T08:32:00+00:00","article_modified_time":"2018-02-08T08:32:48+00:00","author":"S\u0142awomir Ni\u017cnik","twitter_card":"summary_large_image","twitter_misc":{"Written by":"S\u0142awomir Ni\u017cnik"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/"},"author":{"name":"S\u0142awomir Ni\u017cnik","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"headline":"Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products","datePublished":"2017-07-10T08:32:00+00:00","dateModified":"2018-02-08T08:32:48+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/"},"wordCount":52,"articleSection":["Press Materials"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/","url":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/","name":"Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"datePublished":"2017-07-10T08:32:00+00:00","dateModified":"2018-02-08T08:32:48+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/celon-pharma-s-a-received-a-positive-assessment-and-funding-recommendation-from-the-national-centre-for-research-and-development-ncbir-for-3-projects-of-developing-innovative-medicinal-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Celon Pharma S.A. received a positive assessment and funding recommendation from the National Centre for Research and Development (NCBiR) for 3 projects of developing innovative medicinal products"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/44c54386ed112173d6e8bcbeb6425338","name":"S\u0142awomir Ni\u017cnik"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=13799"}],"version-history":[{"count":1,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13799\/revisions"}],"predecessor-version":[{"id":13801,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/13799\/revisions\/13801"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=13799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=13799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=13799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}